HHS se­lects in­tranasal vac­cine can­di­dates for Project NextGen, doles out $500M in funds

HHS on Fri­day an­nounced its se­lec­tions for the next-gen­er­a­tion of Covid-19 vac­cine can­di­dates to re­ceive $500 mil­lion in fund­ing as part of the gov­ern­ment’s Project NextGen.

First an­nounced in May as a fol­low-up to Op­er­a­tion Warp Speed, Project NextGen has a $5 bil­lion bud­get to cre­ate next-gen­er­a­tion Covid-19 vac­cines and treat­ments. The $500 mil­lion in­vest­ment an­nounced Fri­day builds on the $1.4 bil­lion in­vest­ment of­fi­cials an­nounced in Au­gust, which in­clud­ed $326 mil­lion to Re­gen­eron to de­vel­op a new Covid-19 mon­o­clon­al an­ti­body treat­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER